Glass House Seeks NYSE Listing With New Corporate Structure

Glass House Brands is expanding its presence in U.S. capital markets by filing an application to list its subordinate voting shares on the New York Stock Exchange. The California-based operator, one of the state’s largest vertically integrated cannabis companies, is seeking broader investor access as the industry adjusts to the federal government’s recent decision to reclassify medical marijuana to Schedule III.

The company operates one of the largest greenhouse cultivation footprints in the country and has built a portfolio of California-focused brands, including Glass House Farms, PLUS Products, Allswell, and Mama Sue Wellness. The NYSE application marks a significant step for a business that has long emphasized scale, sustainability, and brand development in the nation’s most competitive cannabis market.

Corporate Restructuring Supports NYSE Application

To support its listing effort, Glass House and its indirect wholly owned subsidiary, GHB Usub, entered into a series of agreements to deconsolidate Glass House Retail, the company’s former dual-use business. The restructuring separates medical operations from adult-use activities, which remains a requirement for any U.S. exchange listing under current federal policy.

Under the Deconsolidation Transaction, the subsidiary now holds non-voting, non-participating units in Glass House Retail. A third-party investor holds the voting units. The non-voting units can convert only if the NYSE eventually permits listings from companies that consolidate adult-use cultivation, distribution, or processing. Additional assets will transfer to Glass House Retail automatically once regulatory approvals are secured.

Move Follows Trulieve’s NYSE Debut

Glass House’s application follows Trulieve’s listing on the NYSE, which became effective on June 10 when the Florida-based operator began trading under the symbol TRLV. Trulieve reached the exchange after restructuring to isolate its medical operations, a step designed to comply with federal and exchange requirements in the wake of the government’s April decision to reclassify medical marijuana to Schedule III. Analysts described the move as a targeted response to the new framework rather than evidence of broad institutional appetite for cannabis.

A Small but Growing Group of Early Movers

While not widespread, several operators have taken steps in recent weeks to align themselves with major exchange requirements. Trulieve completed a full deconsolidation. Curaleaf and Verano executed reverse stock splits to meet minimum share-price thresholds. Glass House is now pursuing its own restructuring to support its NYSE application.

For Glass House, the filing represents a strategic attempt to expand liquidity and visibility while its adult-use operations remain structurally separate. The company’s move suggests that more operators may explore similar pathways as the post-rescheduling environment continues to take shape.

Major Exchanges Out of Reach for Most Operators

Despite the significance of cannabis stocks being uplisted to major stock exchanges, Adam Stettner, CEO of investment firm FundCanna, notes that the trend is not relevant for most operators.

“Glass House getting closer to the NYSE is impressive and meaningful, but we shouldn’t confuse the experience of a handful of large public MSOs with the reality facing most cannabis operators,” he writes in a statement to IgniteIt. “Ninety-plus percent of the industry remains privately held and reliant on private capital, trade credit, and specialized lenders.”

“The significance of this development isn’t that thousands of operators suddenly gain access to public markets. They won’t,” he added. “The significance is that each step toward mainstream market acceptance helps reduce stigma, improve investor confidence, and attract additional capital into the cannabis sector over time. That’s a positive development for everyone, even if the direct benefits accrue first to the industry’s largest companies.”